GENERAL25 Sept 2026
Investment of ₹5,210 cr made under PLI scheme for bulk drugs till Jun: Govt
India has drawn ₹5,210 crore of investment under the Production Linked Incentive (PLI) scheme for bulk drugs, as of June. The government is making wide-ranging efforts to raise investment in pharma so that supply of critical active pharmaceutical ingredients (APIs) doesn't get disrupted. If you run a bulk drug or API business, this points to continued government backing for local manufacturing.
Key Statutory Highlights
- Total investment of ₹5,210 crore has been made under the PLI scheme for bulk drugs as of June, the government said.
- The government has made wide-ranging efforts to increase investment in the pharmaceutical sector to build up manufacturing capabilities.
- A stated aim of these efforts is to prevent disruption in the supply of critical APIs.
Actionable Advice for Taxpayers / Founders:If you deal in bulk drugs or APIs, review the PLI scheme guidelines and check whether your expansion or production plans fit the current terms before you apply. Treat any benefit as subject to the scheme's rules, not as guaranteed.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: